BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21175580)

  • 1. Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.
    Horiuchi M; Mogi M
    Br J Pharmacol; 2011 Jul; 163(6):1122-30. PubMed ID: 21175580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.
    Saavedra JM
    Clin Sci (Lond); 2012 Nov; 123(10):567-90. PubMed ID: 22827472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain.
    Saavedra JM; Benicky J; Zhou J
    Cell Mol Neurobiol; 2006; 26(7-8):1099-111. PubMed ID: 16636899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiotensin II type 2 receptor in the brain.
    Horiuchi M; Mogi M; Iwai M
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):1-6. PubMed ID: 19861353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of angiotensin receptor blockers.
    Villapol S; Saavedra JM
    Am J Hypertens; 2015 Mar; 28(3):289-99. PubMed ID: 25362113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.
    Scheen AJ
    Diabetes Metab; 2004 Dec; 30(6):498-505. PubMed ID: 15671919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers.
    Culman J; Blume A; Gohlke P; Unger T
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S64-70. PubMed ID: 12140731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin II receptor blockers on dementia.
    Mogi M; Horiuchi M
    Hypertens Res; 2009 Sep; 32(9):738-40. PubMed ID: 19727113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of angiotensin II receptors beyond the classical pathway.
    Horiuchi M; Iwanami J; Mogi M
    Clin Sci (Lond); 2012 Aug; 123(4):193-203. PubMed ID: 22548405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.
    Saavedra JM; Sánchez-Lemus E; Benicky J
    Psychoneuroendocrinology; 2011 Jan; 36(1):1-18. PubMed ID: 21035950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers.
    Kintscher U; Unger T
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S26-32. PubMed ID: 15868116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with the use of angiotensin receptor blockers in patients with cardiovascular, cerebrovascular and renal diseases.
    Chrysant SG
    Curr Clin Pharmacol; 2006 May; 1(2):139-46. PubMed ID: 18666366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of stroke damage by angiotensin II type 2 receptor stimulation via peroxisome proliferator-activated receptor-gamma activation.
    Shan BS; Mogi M; Iwanami J; Bai HY; Kan-No H; Higaki A; Min LJ; Horiuchi M
    Hypertens Res; 2018 Oct; 41(10):839-848. PubMed ID: 30089862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
    Mogi M; Horiuchi M
    Geriatr Gerontol Int; 2013 Jan; 13(1):13-8. PubMed ID: 22726823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference With Endothelial PPAR (Peroxisome Proliferator-Activated Receptor)-γ Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation.
    Nair AR; Agbor LN; Mukohda M; Liu X; Hu C; Wu J; Sigmund CD
    Hypertension; 2018 Nov; 72(5):1227-1235. PubMed ID: 30354810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do angiotensin receptor blockers prevent Alzheimer's disease?
    Hajjar I; Rodgers K
    Curr Opin Cardiol; 2013 Jul; 28(4):417-25. PubMed ID: 23703253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.
    Min LJ; Mogi M; Shudou M; Jing F; Tsukuda K; Ohshima K; Iwanami J; Horiuchi M
    Hypertension; 2012 May; 59(5):1079-88. PubMed ID: 22454480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation.
    Schulz R; Heusch G
    J Hypertens Suppl; 2006 Mar; 24(1):S123-9. PubMed ID: 16601565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury.
    Li J; Culman J; Hörtnagl H; Zhao Y; Gerova N; Timm M; Blume A; Zimmermann M; Seidel K; Dirnagl U; Unger T
    FASEB J; 2005 Apr; 19(6):617-9. PubMed ID: 15665034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of renin-angiotensin system in adipose tissue dysfunction.
    Iwai M; Horiuchi M
    Hypertens Res; 2009 Jun; 32(6):425-7. PubMed ID: 19407825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.